Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in KenyaAnthony Etyang, George M. Warimwe, Wycliffe Moracha et al.|Clinical Infectious Diseases|2021Cited by 52
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021Anthony Etyang, Ambrose Agweyu, Ifedayo Adetifa et al.|PLOS Global Public Health|2022Cited by 34
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21Ruth Lucinde, Katherine E. Gallagher, Daisy Mugo et al.|PLoS ONE|2022Cited by 30
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022E. Wangeci Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|Influenza and Other Respiratory Viruses|2023Cited by 24
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in KenyaE. Wangeci Kagucia, John N. Gitonga, Catherine Kalu et al.|Open Forum Infectious Diseases|2021Cited by 20